Lee Kalowski - Aug 26, 2021 Form 4 Insider Report for BICYCLE THERAPEUTICS plc (BCYC)

Role
President and CFO
Signature
/s/ Lee Kalowski
Stock symbol
BCYC
Transactions as of
Aug 26, 2021
Transactions value $
-$224,493
Form type
4
Date filed
8/27/2021, 06:31 PM
Previous filing
Aug 25, 2021
Next filing
Sep 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCYC Ordinary Shares Options Exercise $4.82K +550 $8.76 550 Aug 26, 2021 Direct F1, F2
transaction BCYC Ordinary Shares Sale -$19.3K -550 -100% $35.04 0 Aug 26, 2021 Direct F1, F3
transaction BCYC Ordinary Shares Options Exercise $69.4K +7.95K $8.73 7.95K Aug 27, 2021 Direct F1, F4
transaction BCYC Ordinary Shares Sale -$279K -7.95K -100% $35.15 0 Aug 27, 2021 Direct F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCYC Stock Option (Right to Buy) Options Exercise $0 -550 -3.85% $0.00 13.7K Aug 26, 2021 Ordinary Shares 550 $8.76 Direct F1, F2, F6
transaction BCYC Stock Option (Right to Buy) Options Exercise $0 -7.95K -57.95% $0.00 5.77K Aug 27, 2021 Ordinary Shares 7.95K $8.73 Direct F1, F4, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares exercised and sold pursuant to a Rule 10b5-1 trading plan.
F2 This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.374675 to GBP 1.00 as of August 26, 2021.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.01 to $35.05 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (5).
F4 This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.3709 to GBP 1.00 as of August 27, 2021.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.08 to $35.18 inclusive.
F6 25% of the shares vested on January 1, 2020, and the remaining vested or shall vest in 36 equal monthly installments.